Document is current
Any future updates will be listed below
-
Authors
Flanagan, Meghan R. https://orcid.org/0000-0002-2330-6374
Doody, David R.
Voutsinas, Jenna
Wu, Qian
Banda, Kalyan
Sharifi, Nima
Li, Christopher I.
Gadi, Vijayakrishna K.
-
Funding
Funding for this research was provided by:
Swim Across America
- License Information
-
More Information
Article History
Received: 11 March 2022
Accepted: 30 May 2022
First Online: 1 July 2022
Disclosures
: Cleveland Clinic has a patent on <i>HSD3B1</i>, and N.S. is a co-inventor. V.K.G. has speaking honoraria at Genentech, Puma, Seagen, Hologic, and is on the scientific advisory board for Puma, Phoenix Molecular Designs, and New Equilibrium. He has equity stake in SEngine Precision, 3rdEyeBio, Novilla Therapeutics, AmunBio, Phoenix Molecular Designs, New Equilibrium, and there is institutional funding through Agendia and Tizona Therapeutics. None of these are germane to or have influenced the scientific work in this article.
